Article
Novel genetically engineered mouse models for clear cell renal cell carcinoma.
Scientific reports - 22 May 2023
van der Mijn Johannes C, Laursen Kristian B, Fu Leiping, Khani Francesca, Dow Lukas E, Nowak Dawid G, Chen Qiuying, Gross Steven S, Nanus David M, Gudas Lorraine J
Abstract excerpt
Genetically engineered mouse models (GEMMs) are important immunocompetent models for research into the roles of individual genes in cancer and the development of novel therapies. Here we use inducible CRISPR-Cas9 systems to develop two GEMMs which aim to model the extensive chromosome p3 deletion frequently observed in clear cell renal cell carcinoma (ccRCC). We cloned paired guide RNAs targeting early exons of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
